0001771623-20-000001.txt : 20200114 0001771623-20-000001.hdr.sgml : 20200114 20200114105822 ACCESSION NUMBER: 0001771623-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200114 DATE AS OF CHANGE: 20200114 EFFECTIVENESS DATE: 20200114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Valanbio Therapeutics, Inc. CENTRAL INDEX KEY: 0001771623 IRS NUMBER: 473852677 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-348130 FILM NUMBER: 20525280 BUSINESS ADDRESS: STREET 1: 1120 LONGSTONE WAY CITY: RALEIGH STATE: NC ZIP: 27614 BUSINESS PHONE: 919-360-7010 MAIL ADDRESS: STREET 1: 1120 LONGSTONE WAY CITY: RALEIGH STATE: NC ZIP: 27614 D/A 1 primary_doc.xml X0708 D/A LIVE 0001771623 Valanbio Therapeutics, Inc. 1120 LONGSTONE WAY RALEIGH NC NORTH CAROLINA 27614 919-360-7010 DELAWARE None None Corporation true 2015 Clayton Duncan c/o Valanbio Therapeutics, Inc. 1120 Longstone Way Raleigh NC NORTH CAROLINA 27614 Executive Officer Director Sam Hopkins c/o Valanbio Therapeutics, Inc. 1120 Longstone Way Raleigh NC NORTH CAROLINA 27614 Director Eric J. Toone c/o Valanbio Therapeutics, Inc. 1120 Longstone Way Raleigh NC NORTH CAROLINA 27614 Director Pei Zhou c/o Valanbio Therapeutics, Inc. 1120 Longstone Way Raleigh NC NORTH CAROLINA 27614 Executive Officer Director Moise A. Khayrallah c/o Valanbio Therapeutics, Inc. 1120 Longstone Way Raleigh NC NORTH CAROLINA 27614 Executive Officer Director Pharmaceuticals Decline to Disclose 06b true 0001771623-19-000001 2018-08-27 true true false 7000 600000 421000 179000 false 5 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Valanbio Therapeutics, Inc. /s/ Clayton Duncan Clayton Duncan Chief Executive Officer 2020-01-14